BridgeMD
New treatment option for Neonatal Hyperbilirubinemia
Official title Newborn Jaundice - An Investigation of Different Approaches to Light Therapy
ClinicalTrials.gov ID: NCT06702241
What this study is testing
- What it's testing
- Background Neonatal jaundice affects about 60% of full-term newborns in their first week. If untreated, it can lead to permanent brain damage.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 14
You may be able to join if
- Hyperbilirubinemia with a total serum bilirubin level above the limit of necessary treatment according to the Danish Pediatric Society's guidelines
- Birth weight \>1800g
- Gestational age \>33+0
You likely can't join if
- Hyperbilirubinemia within the first 24 hours of life
- Rapidly increasing serum levels of bilirubnemia indicating pathology or hemolysis
The study team makes the final eligibility decision.
Where it's taking place
- Aalborg, Denmark
- Hjørring, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 day to 14 days. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aalborg, Denmark; Hjørring, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.